Practice patterns to decrease myopia progression differ among paediatric ophthalmologists around the world

@article{Leshno2019PracticePT,
  title={Practice patterns to decrease myopia progression differ among paediatric ophthalmologists around the world},
  author={Ari Leshno and Sonal K. Farzavandi and Rosario G{\'o}mez-de-Lia{\~n}o and Derek T. Sprunger and Tamara Wygnanski-Jaffe and Eedy Mezer},
  journal={British Journal of Ophthalmology},
  year={2019},
  volume={104},
  pages={535 - 540}
}
Introduction Myopia is a worldwide epidemic. Plethora of treatments are offered to decrease myopia progression. In this study, we compared between different geographical areas worldwide the practice patterns used by paediatric ophthalmologists to decrease the progression of myopia. Methods Global responses to a questionnaire were analysed (n=794) for demographic variations. Pharmacological, optical and behavioural categories were defined as effective or ineffective based on the current… 
5 Citations
Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute
TLDR
The European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia, where the pathogenesis and genetics of the myopia are summarized, and epidemiology, risk factors, preventive and treatment options are discussed in details.
Annual Myopia Progression and Subsequent 2-Year Myopia Progression in Singaporean Children
TLDR
One-year myopia progression and age at baseline were associated with subsequent 2-yearMyopia progression in children 7 to 9 years of age and may be considered by eye care practitioners as two of several factors that may be associated with future myopia progressions in children.
Myopia Control 2020: Where are we and where are we heading?
  • M. Bullimore, K. Richdale
  • Medicine
    Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians
  • 2020
TLDR
This review arms practitioners with the evidence‐based information they need to fully manage myopia and provides guidance on how to identify and treat myopia in patients.
A system to monitor one's nearsightedness implicitly
Efficacy in myopia control
There is rapidly expanding interest in interventions to slow myopia progression in children and teenagers, with the intent of reducing risk of myopia-associated complications later in life. Despite

References

SHOWING 1-10 OF 29 REFERENCES
Current trends among pediatric ophthalmologists to decrease myopia progression—an international perspective
TLDR
Most pediatric ophthalmologists treat to decrease myopia, and atropine 0.01% is the most popular and safe modality used similarly to recent reports, however, there is no consensus when treatment should be initiated.
Effectiveness study of atropine for progressive myopia in Europeans
TLDR
Despite the relatively high occurrence of adverse events, this study shows that atropine can be an effective and sustainable treatment for progressive high myopia in Europeans.
Current approaches to myopia control
  • S. Leo
  • Medicine
    Current opinion in ophthalmology
  • 2017
TLDR
Myopia control can be achieved by slowing the onset of myopia, which now appears to be possible through increasing time outdoors and slowing the progression of myopic progression with interventions like atropine and orthokeratology.
Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis.
TLDR
It is indicated that a range of interventions can significantly reduce myopia progression when compared with single vision spectacle lenses or placebo, and pharmacologic interventions, that is, muscarinic antagonists such as atropine and pirenzepine were effective.
Atropine for the Prevention of Myopia Progression in Children: A Report by the American Academy of Ophthalmology.
TLDR
Level I evidence supports the use of atropine to prevent myopic progression and there are reports of myopic rebound after treatment is discontinued, this seems to be minimized by using low doses.
Topical Atropine in the Control of Myopia
TLDR
Topical atropine 0.01% has the best therapeutic index, with clinically insignificant amounts of pupil dilation, near vision, and accommodation loss but remains as effective as higher doses.
The epidemics of myopia: Aetiology and prevention
TLDR
Combining increased time outdoors in schools, to slow the onset of myopia, with clinical methods for slowing myopic progression, should lead to the control of this epidemic, which would otherwise pose a major health challenge.
Incidence and progression of myopia and associated factors in urban school children in Delhi: The North India Myopia Study (NIM Study)
TLDR
Outdoor activities / time spent outdoors> 2 hours in a day were protective with an inverse association with progression of myopia (P< 0.001), and hours of reading-writing/week, use of computers/ video games, and watching television were significant risk factors for progression ofMyopia.
The Synergistic Effects of Orthokeratology and Atropine in Slowing the Progression of Myopia
TLDR
Combined treatment with atropine and OK lenses would be a choice of treatment to control the development of myopia.
Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000.
TLDR
The cause of the relative increasing severity of myopia among the schoolchildren was due to the onset of myopic at a very young, and progressively-decreasing, age over the study period, and more attention should be paid to the eye care of pre-schoolchildren.
...
1
2
3
...